Now through March 31, shop at participating local retailers and help raise money for the cause.Find Shamrocks Near Me
Each day these freedoms are taken away from kids and adults with muscular dystrophy, ALS and related diseases that weaken muscle strength and limit mobility. Together we can change that.
MDA is supporting
Kids and adults make
visits to MDA Care Centers each year
More than 3,800 kids receive their “best week of the year” at MDA Summer Camp, free of charge
You’ve helped make
this progress and more possible
Following the unprecedented approval of three drugs in six months to treat neuromuscular diseases, we're pushing for more progress with new research funding this winter.
CMT doesn’t hold Nicki back; it pushes her to reach higher. Literally. Read on to follow Nicki on the trek of a lifetime — to the top of Mount Kilimanjaro, the tallest mountain in Africa.
For 35 years, retail partners nationwide have sold iconic paper shamrocks to help kids and adults living with muscular dystrophy, ALS and related life-threatening diseases live longer and grow stronger.
When opportunity knocks, 15-year-old Justin answers. Born with CMD, Justin has traveled to China, been on a 500-mile bike ride across Iowa, and even modeled in a fashion show. How? Justin always says, ‘Yes.’ That’s how he lives unlimited.
When I was asked to continue in my role as National Ambassador for MDA in 2017, I had to think about it for about a nanosecond before I gave my answer. Yes, of course! Sot it’s official: I’ve re-upped for another tour,” said Joe.
On Dec. 23, 2016, the SMA community achieved a goal that would not have been possible without the support and dedication of the families, physicians and researchers who have passionately pursued a treatment for spinal muscular atrophy. We are proud to announce that SPINRAZA™ (nusinersen) has been approved by the FDA.
College. Jobs. Life on your own. This is a big time in your life, and we’re here for you – and with you – with brand-new resources and opportunities.
The FDA has granted accelerated approval to eteplirsen for the treatment of Duchenne muscular dystrophy! Decades of MDA research and investment have paid off with the first disease-modifying drug available to treat DMD. We are filled with hope.
Our trained specialists are here to provide one-on-one support for every part of your journey. Send a message below or call us at 800-572-1717. If you live outside the U.S., we may be able to connect you to muscular dystrophy groups in your area, but MDA services are only available in the U.S.